Central Nervous System Migraine

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Migraine Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Migraine Projects
--Alexza Pharmaceuticals Inc
--Addex Pharmaceuticals SA
--Boehringer Ingelheim GmbH
--Allergan Inc
--Dainippon Sumitomo Pharma Co., Ltd.
--CRT Pharmaceuticals, Inc.
--Eisai Co Ltd
--Desitin Arzneimittel GmbH
--GlaxoSmithKline plc
--Faust Pharmaceuticals
--Lupin Ltd
--Intranasal Therapeutics, Inc
--erly Intranasal Technology, Inc.)
--Merck & Co Inc
--MAP Pharmaceuticals, Inc.
--Par Pharmaceutical Companies Inc
--Mylan, Inc.
--Ranbaxy Laboratories Ltd.
--ProEthic Pharmaceuticals, Inc.
--Winston Laboratories, Inc.
--Solvay S.A.

--Top Companies in early stage Migraine Projects
--Biofrontera AG
--Ariston Pharmaceuticals, Inc.
--BTG plc
--Britannia Pharmaceuticals Limited
--Glenmark Pharmaceuticals Limited
--D-Pharm Ltd
--Novartis AG
--NeurAxon Inc.
--NuPathe Inc.
--Noven Pharmaceuticals Inc
--Pierre Fabre Medicament
--Pfizer Inc
--TorreyPines Therapeutics, Inc.
--Spherics, Inc
--Vyteris Holdings
--da) Inc
--Vectura Group plc.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View